Assorted Croissant:: sold in 4 pack clamshell package. Ingredients: Plain Croissant: ( dough [enriched unbleached flour (wheat flour, ma...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1286-2017.
Labeling for Croissants sold in Northern CA fails to declare egg in the ingredients list or allergen information. The croissants are manufactured with an egg wash.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1286-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Bakers Of Paris, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1286-2017.
Bakers Of Paris, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Bakers Of Paris, Inc. Recall FAQ
Bakers Of Paris, Inc. is the subject of a dairy safety report: Assorted Croissant:: sold in 4 pack clamshell package. Ingredients: Plain Croissant: ( dough [enriched unbleached flour (wheat flour, ma.... The notice was published on January 3, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.